• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CURONIX LLC FREEDOM PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CURONIX LLC FREEDOM PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number STQ4-RCV-A0, STQ4-SPR-B0
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/26/2024
Event Type  Injury  
Manufacturer Narrative
The other adverse events issues questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device at an off-label location has been ruled out as a potential cause.Potential causes of the reported issue are severe force applied to implant, severe force or bending during implantation, improper surgical technique, manufacturing issue, excessive pressure on the electrode array, and using incorrect tools at the time of the implant.However, the neurostimulator was fractured while attempting to explant the device.The stimulator is used to treat pain.The cause of the fractured lead is due to incorrect surgical technique as the neurostimultor was fractured during the explant procedure (user error - clinician).Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, a capa is not required.Other adverse events issues rates will continue to be tracked and trended.
 
Event Description
As of (b)(6) 2020 the patient was receiving adequate therapy and the devices were helping with ilioinguinal and low back pain.On january 26, 2024, support received a call regarding mri clearance.An explant procedure was performed on (b)(6) 2020 where one neurostimulator was completely removed and the other was partially removed as it was fractured while attempting to explant.The reason for the explant procedure is unknown and there are no plans to remove the remaining portion.Additionally, it is unknown which device remains partially implanted.The surgeon noted the remaining portion of the neurostimulator is in the muscle tissue and since it isn't causing damage, harm, or risk, they didn't advise the patient to have it removed.
 
Manufacturer Narrative
The other adverse events issues questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device at an off-label location has been ruled out as a potential cause.Potential causes of the reported issue are severe force applied to implant, severe force or bending during implantation, improper surgical technique, manufacturing issue, excessive pressure on the electrode array, and using incorrect tools at the time of the implant.However, the neurostimulator was fractured while attempting to explant the device.The stimulator is used to treat pain.The cause of the fractured lead is due to incorrect surgical technique as the neurostimultor was fractured during the explant procedure (user error - clinician).Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, a capa is not required.Other adverse events issues rates will continue to be tracked and trended.
 
Event Description
As of (b)(6) 2020 the patient was receiving adequate therapy and the devices were helping with ilioinguinal and low back pain.On (b)(6) 2024, support received a call regarding mri clearance.An explant procedure was performed on (b)(6) 2020 where one neurostimulator was completely removed and the other was partially removed as it was fractured while attempting to explant.The reason for the explant procedure is unknown and there are no plans to remove the remaining portion.Additionally, it is unknown which device remains partially implanted.The surgeon noted the remaining portion of the neurostimulator is in the muscle tissue and since it isn't causing damage, harm, or risk, they didn't advise the patient to have it removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREEDOM PERIPHERAL NERVE STIMULATOR
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
CURONIX LLC
1310 park central blvd s
pompano beach FL 33064
Manufacturer (Section G)
CURONIX LLC
1310 park central blvd s
pompano beach FL 33064
Manufacturer Contact
tena jimmerson
1310 park central boulevard s.
pompano beach, FL 33064
8009655134
MDR Report Key18764042
MDR Text Key336052881
Report Number3010676138-2024-00017
Device Sequence Number1
Product Code GZF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 02/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/22/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/01/2021
Device Model NumberSTQ4-RCV-A0, STQ4-SPR-B0
Device Lot NumberSWO190410, SWO190424
Was Device Available for Evaluation? No
Date Manufacturer Received01/26/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/29/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age82 YR
Patient SexMale
-
-